- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07637097
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia (VOCALE LBD)
3. juni 2026 opdateret af: Oleg Zaslavsky, University of Washington
Reducing Depression in Family Caregivers of Persons Living With Lewy Body Dementia Through Tailored Asynchronous Online Intervention.
This study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in family caregivers of people with Lewy Body Dementia (LBD), compared to standard educational materials.
LBD is the second most common form of degenerative dementia and causes distinct challenges, including visual hallucinations, REM sleep disorder, and severe motor symptoms, that are not addressed by generic caregiver interventions.
Depression rates in LBD caregivers reach 40-50%, double the rate seen in Alzheimer's disease caregivers, yet no rigorous digital interventions exist specifically for this population.
VOCALE LBD is a text-based, low-bandwidth platform (Discourse) that brings groups of 10-15 caregivers together in an 8-week moderated online community.
Weekly topics address LBD-specific challenges (sleep problems, hallucinations, self-care) and problem-solving skills using the ADAPT method.
A pilot study (n=54) showed strong effects on depressive symptoms (Cohen's d=0.54 at 1-month follow-up), near-perfect engagement, and high participant satisfaction.
This RCT (N=220) will test efficacy, examine mechanisms of action (self-efficacy and problem-solving), and explore analytics approaches for pragmatic monitoring, laying groundwork for future implementation in clinics and community organizations.
Studieoversigt
Status
Ikke rekrutterer endnu
Detaljeret beskrivelse
Over 1.4 million people in the U.S. are diagnosed with Lewy Body Dementia (LBD).
Up to 80% receive care from family members, yet family caregivers of people with LBD experience depression at rates (40-50%) double those of Alzheimer's disease caregivers.
LBD's distinct features - visual hallucinations, REM sleep behavior disorder, cognitive fluctuations, and Parkinsonian motor symptoms - create caregiving demands not addressed by existing dementia caregiver interventions.
Current pharmacological treatments for LBD are largely experimental, leaving families to manage severe behavioral and motor symptoms without adequate support.
INTERVENTION: VOCALE LBD (Virtual Online Communities for Aging Life Experiences - Lewy Body Dementia) is a fully asynchronous, text-based online group intervention delivered via the Discourse platform.
The 8-week program includes icebreaker activities followed by LBD-specific weekly topics (self-care, sleep problems, hallucinations and delusions) and problem-solving training using the ADAPT method (Adopting a positive attitude, Defining the problem, brainstorming Alternatives, Predicting consequences, Trying the solution).
Groups of 10-15 caregivers are moderated by a licensed nurse or social worker (RN/LCSW), who logs in daily and facilitates discussions.
The platform requires no video conferencing and is accessible via any internet-connected device.
Loaner devices and digital literacy training are provided for participants who need them.
STUDY DESIGN: Two-arm, randomized controlled trial.
Participants are randomized 1:1 to (a) VOCALE LBD or (b) Standard of Care (SOC: NIA psychoeducational materials, LBDA resource list, problem-solving handouts).
Assessment time points: baseline, post-intervention (week 8), and 6-month follow-up.
Exit interviews are conducted at the end of the intervention.
AIMS: Aim 1 tests whether VOCALE LBD reduces depressive symptoms (CES-D) compared to SOC at week 8, with sustained effect at 6 months.
Aim 2 examines mechanisms - whether self-efficacy and problem-solving mediate outcomes (2a quantitative mediation; 2b qualitative analysis).
Aim 3 explores pragmatic monitoring using user engagement analytics, natural language processing, and LLM-assisted moderator support tools.
RECRUITMENT: Nationwide recruitment through the Lewy Body Dementia Association (LBDA) via eblasts, social media, support groups, and print materials.
Additional outreach via Alzheimer.gov
and national LBD caregiver web resources.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
220
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Oleg Zaslavsky, PhD, RN
- Telefonnummer: (206) 849-3301
- E-mail: zaslav@uw.edu
Studiesteder
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98195
- University of Washington
-
Kontakt:
- Oleg Zaslavsky, PhD, RN
- Telefonnummer: (206) 849-3301
- E-mail: zaslav@uw.edu
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Current family member or informal (unpaid) caregiver of a person with a confirmed diagnosis of Lewy Body Dementia (LBD) or LBD mixed pathology
- Experiences depressive symptoms as defined by a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9)
- Able to read, write, and speak English
- Has access to a device (computer, tablet, or smartphone) that can connect to the internet and be used for videoconferencing or phone calls, OR is interested in using a loaner device
Exclusion Criteria:
- Active suicidal ideation as indicated by endorsement of PHQ-9 Item 9 (thoughts that you would be better off dead, or thoughts of hurting yourself)
- Paid or professional caregiver (must be unpaid family/informal caregiver)
- Unable to read, write, or speak English
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: VOCALE LBD
Participants in this arm receive the VOCALE LBD intervention: an 8-week, fully asynchronous, text-based online group program delivered via the Discourse platform.
Groups of 10-15 participants are moderated by a licensed nurse or social worker who logs in daily.
Weekly discussion topics address LBD-specific caregiving challenges (self-care, sleep problems, hallucinations and delusions) and problem-solving skills training using the ADAPT method.
Participants are asked to post at least twice weekly.
|
The 8-week VOCALE LBD intervention is delivered asynchronously via the Discourse online platform.
The weekly curriculum includes: Pre-intervention (icebreakers, self-introductions); Week 1 (self-care); Week 2 (sleep problems); Week 3 (hallucinations and delusions); Week 4 (problem-solving inventory, SPSI-R); Week 5 (ADAPT - Positive Attitude); Week 6 (ADAPT - Define the Problem); Week 7 (ADAPT - Alternative Solutions); Week 8 (ADAPT - Plan and Try).
Andre navne:
|
|
Aktiv komparator: Standard of Care
NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout.
Materials delivered via email or mail per participant preference.
|
NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout.
Materials delivered via email or mail per participant preference.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Depressive Symptoms, Center for Epidemiologic Studies Depression Scale (CES-D)
Tidsramme: Baseline (pre-randomization), Post-Intervention (Week 8), 6-Month Follow-Up
|
The CES-D measures the frequency of depressive symptoms in the past week, including negative mood, guilt and worthlessness, and physical symptoms associated with depression.
20-item scale; higher scores indicate greater depressive symptom burden.
Validated for use in dementia caregiving populations
|
Baseline (pre-randomization), Post-Intervention (Week 8), 6-Month Follow-Up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Perceived stress (PSS)
Tidsramme: Baseline, Week 8, 6-month Follow-up
|
10-item scale measuring perceived stress in the past month.
Higher scores = greater stress
|
Baseline, Week 8, 6-month Follow-up
|
|
Social Support (MOS)
Tidsramme: Baseline, Week 8, 6-month follow-up
|
Medical Outcomes Study (MOS) Social Support Scale: measures emotional, tangible, affectionate, and positive social interaction.
Higher scores = greater support.
|
Baseline, Week 8, 6-month follow-up
|
|
Caregiving Burden
Tidsramme: Baseline, Week 8, 6 month follow-up
|
Short Zarit Caregiver Burden Interview: 12-item measure of caregiver burden covering personal strain and role strain.
Higher scores = greater burden.
|
Baseline, Week 8, 6 month follow-up
|
|
Loneliness
Tidsramme: Baseline, Week 8, 6 month follow-up
|
UCLA Loneliness Scale: measures subjective feelings of loneliness and social isolation.
Higher scores = greater loneliness
|
Baseline, Week 8, 6 month follow-up
|
|
Platform Engagement
Tidsramme: Post Intervention (week 8)
|
Platform Engagement (UES) User Engagement Scale (UES): characterizes quality of users' interactions with the Discourse platform (focused attention, perceived usability, aesthetics, reward).
Post-Intervention (Week 8)
|
Post Intervention (week 8)
|
|
Problem Solving
Tidsramme: Baseline, Week 4, Week 8, 6-month followup
|
Social Problem Solving Inventory - Revised (SPSI-R): assesses problem-solving orientation and style.
Used as mechanistic measure (Aim 2a).
|
Baseline, Week 4, Week 8, 6-month followup
|
|
Health Self-Efficacy
Tidsramme: Baseline, Week 4, Week 8, 6-month follow-up
|
Health Self-Efficacy 5-item Health Self-Efficacy Measure: assesses confidence in managing health-related tasks.
Used as mechanistic measure (Aim 2a).
|
Baseline, Week 4, Week 8, 6-month follow-up
|
|
Sustained Effect on Depression (CES-D)
Tidsramme: 6-Month Follow-up
|
CES-D at 6-month follow-up: tests sustained (durable) reduction in depressive symptoms beyond the active intervention period.
|
6-Month Follow-up
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. december 2026
Primær færdiggørelse (Anslået)
30. november 2029
Studieafslutning (Anslået)
30. november 2030
Datoer for studieregistrering
Først indsendt
3. juni 2026
Først indsendt, der opfyldte QC-kriterier
3. juni 2026
Først opslået (Faktiske)
9. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
9. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
3. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Synukleinopatier
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Psykiske lidelser
- Adfærdsmæssige symptomer
- Neurokognitive lidelser
- Demens
- Neurodegenerative sygdomme
- Bevægelsesforstyrrelser
- Stress, psykologisk
- Parkinsonlidelser
- Basal Ganglia Sygdomme
- Opførsel
- Plejerbyrde
- Lewy Body sygdom
Andre undersøgelses-id-numre
- A214588
- 1R01MH139601-01A1 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified individual participant data that underlie the results reported in publications (text, tables, figures, appendices) will be shared.
Data will be made available 9 months following publication of the primary study results.
Data will be deposited in an NIH-designated repository (e.g., NIMH Data Archive or ICPSR).
Requests for data should include a data analysis plan and be submitted to the PI.
IPD-delingstidsramme
Beginning 9 months after publication of primary outcome results; available for 5 years.
IPD-delingsadgangskriterier
Researchers who provide a methodologically sound data analysis plan.
Proposals should be directed to zaslav@uw.edu.
To gain access, data requestors will need to sign a data access agreement.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .